全文获取类型
收费全文 | 2902篇 |
免费 | 239篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 79篇 |
妇产科学 | 85篇 |
基础医学 | 508篇 |
口腔科学 | 54篇 |
临床医学 | 158篇 |
内科学 | 736篇 |
皮肤病学 | 107篇 |
神经病学 | 246篇 |
特种医学 | 71篇 |
外科学 | 429篇 |
综合类 | 16篇 |
预防医学 | 240篇 |
眼科学 | 32篇 |
药学 | 195篇 |
中国医学 | 2篇 |
肿瘤学 | 165篇 |
出版年
2023年 | 21篇 |
2022年 | 25篇 |
2021年 | 78篇 |
2020年 | 51篇 |
2019年 | 104篇 |
2018年 | 97篇 |
2017年 | 64篇 |
2016年 | 62篇 |
2015年 | 84篇 |
2014年 | 112篇 |
2013年 | 122篇 |
2012年 | 155篇 |
2011年 | 184篇 |
2010年 | 101篇 |
2009年 | 97篇 |
2008年 | 146篇 |
2007年 | 135篇 |
2006年 | 158篇 |
2005年 | 136篇 |
2004年 | 134篇 |
2003年 | 130篇 |
2002年 | 128篇 |
2001年 | 93篇 |
2000年 | 96篇 |
1999年 | 79篇 |
1998年 | 50篇 |
1997年 | 30篇 |
1996年 | 32篇 |
1995年 | 26篇 |
1994年 | 29篇 |
1993年 | 11篇 |
1992年 | 35篇 |
1991年 | 37篇 |
1990年 | 47篇 |
1989年 | 30篇 |
1988年 | 31篇 |
1987年 | 27篇 |
1986年 | 15篇 |
1985年 | 28篇 |
1984年 | 10篇 |
1983年 | 18篇 |
1979年 | 9篇 |
1978年 | 6篇 |
1977年 | 5篇 |
1975年 | 9篇 |
1974年 | 7篇 |
1973年 | 5篇 |
1972年 | 8篇 |
1968年 | 5篇 |
1966年 | 9篇 |
排序方式: 共有3151条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Aneurisma de aorta abdominal infrarrenal en asociación con riñón en herradura: aportación de un caso
Nerea Senarriaga Ruiz de la Illa Reyes Vega Manrique Isabel Lacasa Viscasillas Iñaki Iriarte Soldevilla Miguel Unda Urzaiz 《Actas urologicas espa?olas》2009,33(10):1141-1144
We review the association between surgically resolvable aortic disease and horseshoe kidney with a discussion of diagnostic problems and therapeutic options.Male patient 81 years of age with horseshoe kidney and an abdominal aortic aneurysm that was discovered by chance in an abdominal ultrasound during a check-up for his prostate condition.A retroperitoneal approach was used in order to resect the aneurysm and perform an aorto-aortic bypass with no complications occurring. Two years after the diagnosis, the patient is still asymptomatic from a vascular point of view.The co-presence of horseshoe kidney and aortic disease needing surgical correction is infrequent, but it significantly increases the technical complexity of aortic reconstruction. A literature review is included. 相似文献
5.
6.
7.
8.
The authors studied the effects of 4-hydroxyandrostene-3,17-dione (4-OHA) on progesterone (P), 17 beta-estradiol (E2), and 20 alpha-hydroxy-4-pregnen-3-one synthesis and pregnenolone accumulation in cultured human midluteal cells. A dose-dependent inhibition with and without human chorionic gonadotropin (hCG) of E2 and P production was observed. The accumulation of pregnenolone was significantly enhanced three to fourfold by 4-OHA in this culture system, as compared with control value. In addition, a sevenfold increase on pregnenolone accumulation was observed in the presence of 4-OHA plus 10 IU of hCG as compared with control values and 2.2-fold as compared with the 4-OHA treatments. These in vitro findings indicate a direct effect of 4-OHA on luteal steroidogenesis. Nevertheless, the suppressive effect of 4-OHA on P and E2 production is located at different sites of the steroidogenic pathway. In addition, the results demonstrate that hCG in the presence of 4-OHA stimulated pregnenolone accumulation, suggesting that the inhibition of P synthesis is in some steps after the formation of pregnenolone. These data indicate that the actions of 4-OHA on P or E2 formation have different inhibitory mechanisms. 相似文献
9.
10.
Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. 总被引:23,自引:2,他引:21 下载免费PDF全文
R Bucala Z Makita G Vega S Grundy T Koschinsky A Cerami H Vlassara 《Proceedings of the National Academy of Sciences of the United States of America》1994,91(20):9441-9445
Atherosclerosis develops rapidly in patients with diabetes or renal insufficiency. Plasma lipoprotein profiles are frequently abnormal in these conditions and reflect an elevation in the level of the apoprotein B (ApoB)-containing components very low density lipoprotein (VLDL) and low density lipoprotein (LDL). High levels of circulating advanced glycation end products (AGEs) also occur in diabetes and end-stage renal disease (ESRD). These products arise from glucose-derived Amadori products and include AGE-modified peptides (AGE-peptides) which result from the catabolism of AGE-modified tissue proteins. AGE-peptides have been shown to crosslink protein amino groups and to accumulate in plasma as a consequence of renal insufficiency. To address potential mechanisms for the dyslipidemia of diabetes and ESRD, we investigated the possibility that circulating AGEs react directly with plasma lipoproteins to prevent their recognition by tissue LDL receptors. AGE-specific ELISA showed a significantly increased level of AGE-modified LDL in the plasma of diabetic or ESRD patients compared with normal controls. AGE-LDL formed readily in vitro when native LDL was incubated with either synthetic AGE-peptides or AGE-peptides isolated directly from patient plasma. LDL which had been modified by AGE-peptides in vitro to the same level of modification as that present in the plasma of diabetics with renal insufficiency exhibited markedly impaired clearance kinetics when injected into transgenic mice expressing the human LDL receptor. These data indicate that AGE modification significantly impairs LDL-receptor-mediated clearance mechanisms and may contribute to elevated LDL levels in patients with diabetes or renal insufficiency. This hypothesis was further supported by the observation that the administration of the advanced glycation inhibitor aminoguanidine to diabetic patients decreased circulating LDL levels by 28%. 相似文献